By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Antiandrogens > Enzalutamide > Enzalutamide Dosage
Antiandrogens
https://themeditary.com/dosage-information/enzalutamide-dosage-361.html

Enzalutamide Dosage

Drug Detail:Enzalutamide (Enzalutamide [ enz-a-loot-a-mide ])

Drug Class: Antiandrogens Hormones / antineoplastics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Prostate Cancer

160 mg (four 40 mg capsules) orally once a day

Comments:

  • This drug can be taken with or without food.
  • Swallow capsules whole. Do not chew, dissolve, or open the capsules.
  • Patients receiving this drug should also receive a gonadotropin-releasing hormone (GnRH) analog concurrently or should have had bilateral orchiectomy.

Use: Metastatic and non-metastatic castration-resistant prostate cancer

Renal Dose Adjustments

Mild or moderate renal impairment: No adjustment recommended.
Severe renal impairment or end-stage renal disease: Caution recommended.

Liver Dose Adjustments

No adjustment recommended.

Dose Adjustments

Grade 3 or more toxicity or intolerable side effect:

  • Withhold dosing for one week or until symptoms improve to Grade 2 or less, then resume at usual dose or reduce dose to 120 mg or 80 mg once daily if necessary.

Strong CYP450 2C8 inhibitors:
  • Avoid concomitant use. If concomitant use is necessary, reduce dose to 80 mg once daily and return to the prior dose if the strong CYP450 2C8 inhibitor is discontinued.

Strong CYP450 3A4 inducers:
  • The concomitant use of strong CYP450 3A4 inducers should be avoided if possible. If coadministration is necessary, increase the dose to 160 to 240 mg once daily. If the strong CYP450 3A4 is discontinued, the dose should be returned to the dose used prior to initiation of the strong CYP450 3A4 inducer.

Precautions

CONTRAINDICATIONS:

  • None

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Take with or without food.
  • Swallow capsules whole with water. Do not chew, dissolve, or open the capsules.

Patient advice:
  • This drug is not indicated for use in women. Fetal harm may occur with this drug; avoid pregnancy during therapy. If pregnancy occurs, contact your doctor immediately.
  • If your sexual partner is pregnant, you must use a condom during and for 3 months after treatment with this drug. If your sexual partner has the possibility of becoming pregnant, you must use a condom and another form of birth control during and for 3 months after treatment with this drug. Talk with your doctor if you have questions about birth control.
  • Due to risk of seizure associated with this drug, tell your doctor if you have a history of seizures or any other predisposing factors, including but not limited to brain injury, stroke, or brain tumors.
  • Due to risk of seizure associated with this drug, avoid activities where a sudden loss of consciousness could cause serious harm to yourself or others.
  • This drug may cause side effects including but not limited to fatigue, back pain, diarrhea, infections, dizziness, falls, and problems thinking clearly. Tell your doctor if you have any side effect that bothers you or does not go away.

Frequently asked questions

  • Erleada vs. Xtandi: What's the difference?
  • Does it lower prostate-specific antigen (PSA)?
  • Is this a chemotherapy drug and how does it work?
  • What is it used for?
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by